After a Hot Start to the Year, the Schwab U.S. Dividend Equity ETF (SCHD) Has Gone Practically Nowhere for 5 Months. Is It a Buying Opportunity for Value Investors?

The Schwab U.S. Dividend Equity ETF (SCHD) is up 18.1% year-to-date, but its performance has lagged over the last five months (+3.4% vs. the S&P 500’s +10.9%) as megacap tech and semiconductors have driven index gains. The ETF’s yield is 3.3% versus the S&P 500’s ~1%, supported by its value/ dividend focus (55.1% in consumer staples, healthcare, and energy) and an ultra-low 0.06% expense ratio. Key risk for investors is potential continued underperformance versus growth as AI- and semiconductor-linked stocks lead the broader market.

Analysis

This is less a stock-specific story than a factor-regime signal: the market is rewarding earnings leverage to AI/semis and punishing portfolios that monetize stability over upside convexity. A high-distribution sleeve like SCHD can look attractive on yield screens, but in a tape dominated by a handful of growth leaders, the opportunity cost of missing the index’s top beta is the real drag; that can persist for months even if the ETF remains fundamentally sound.

The second-order winner is the growth complex that keeps pulling passive flows toward QQQ/SMH-style exposures, not the dividend basket itself. Within SCHD, TXN and QCOM provide only token participation in semis, so they do not meaningfully offset the fund’s underweight to the names that are driving benchmark returns. For Charles Schwab, the indirect benefit is asset-gathering optics, but the revenue sensitivity is modest; this is not a material earnings catalyst for SCHW versus rates, cash sweep, or brokerage flows.

The main risk to the underperformance thesis is a sharp reversal in rates or a growth scare that rotates capital back into defensives and income. Over 1-3 months, the key falsifier is a breadth broadening where value and dividends start matching leadership while 10-year yields fall enough to revive duration-sensitive sectors. Over 6-18 months, if the AI capex cycle matures and mega-cap growth de-rates, SCHD’s lower volatility and yield could reassert itself, but that is a macro call, not a near-term catalyst.

Consensus is missing that “safe yield” is not the same as “good total return” in a market where index math is increasingly concentrated. The move in dividend ETFs may be underdone only if investors are using them as a parking place ahead of a rate-cut regime; otherwise the current lag can continue without much fundamental deterioration. This is a rotation problem, not a quality problem.

Key Decisions for Investors

• Pair trade: long QQQ or SMH vs short SCHD for 1-3 months; size for a 4-6% relative return target if semis and AI leadership persists. Cover if 10Y yields break materially lower or if breadth rotates into defensives/value for more than two consecutive weeks.
• Do not add SCHD aggressively here; wait for a 5%+ relative drawdown versus SPY or a clear Fed repricing toward cuts before buying. The risk/reward is better on mean reversion after a washout than chasing a stable-yield vehicle in a growth-led tape.
• For income with growth beta, prefer staying in JEPQ only if your objective is cash flow and you accept upside caps; otherwise own QQQ unhedged while the trend is intact. If Nasdaq strength extends another 5-7%, covered-call structures should underperform materially versus plain beta.
• Watch SCHW as a flow beneficiary, not a direct earnings story; no actionable long unless ETF inflows accelerate enough to matter to total assets. If that data shows up, it is a secondary, low-conviction tailwind rather than a primary trade.